# A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows

> **NCT00752258** · PHASE3 · COMPLETED · sponsor: **Mentor Worldwide, LLC** · enrollment: 576 (actual)

## Conditions studied

- Glabellar Rhytides

## Interventions

- **DRUG:** Mentor Purified Toxin Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT00752258
- **Lead sponsor:** Mentor Worldwide, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 576 (ACTUAL)
- **Last updated:** 2011-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752258, "A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00752258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*